OptimizeRx Corporation (OPRX) Net margin 2016–2025
OptimizeRx Corporation (OPRX) net profit margin by fiscal year — reported net income divided by reported revenue.
4.7%FY2025 · since FY2016: -19.9% → 4.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.7% | +26.5 pp |
| FY2024 | -21.8% | +2.7 pp |
| FY2023 | -24.6% | +1091.4 pp |
| FY2022 | -1115.9% | -1124.3 pp |
| FY2021 | 8.4% | +13.5 pp |
| FY2020 | -5.1% | +7.7 pp |
| FY2019 | -12.8% | -13.8 pp |
| FY2018 | 1.1% | +18.4 pp |
| FY2017 | -17.3% | +2.5 pp |
| FY2016 | -19.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OPRX financial trends
OPRX RevenueOPRX Net incomeOPRX Gross profitOPRX Gross marginOPRX Operating incomeOPRX Operating marginOPRX Operating cash flowOPRX Free cash flowOPRX Capital expendituresOPRX Return on equityOPRX Stock buybacksOPRX Dividends paidOPRX Total assetsOPRX Total liabilitiesOPRX Shareholders’ equityOPRX overview →